Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04537871 · ClinicalTrials.gov registry record

Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study

A clinical trial of Acute Myeloid Leukemia and Myelodysplastic Syndrome, sponsored by City of Hope Medical Center.

Active
Registry status
350
Enrollment target
1
Study location

NCT04537871 is a study of Acute Myeloid Leukemia and Myelodysplastic Syndrome that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 350 participants, above the 115-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (204% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04537871, a study of Acute Myeloid Leukemia and Myelodysplastic Syndrome, is active but no longer recruiting, sponsored by City of Hope Medical Center.

ACTIVE NOT RECRUITING
Registry status
350 participants
Enrollment target
1
Study location

Study Summary

This study evaluates how well the heart, lungs, and muscles are working individually, and how these systems are working together in transplant survivors. Information collected in this study may help doctors to understand why hematopoietic stem cell transplant survivors are at higher risk for developing cardiovascular disease.

Conditions Studied

Acute Myeloid Leukemia Myelodysplastic Syndrome Acute Lymphoblastic Leukemia Hematopoietic and Lymphoid Cell Neoplasm Non-Hodgkin Lymphoma Hodgkin Lymphoma Plasma Cell Myeloma

Interventions

  • PROCEDURE Biospecimen Collection
  • PROCEDURE Echocardiography
  • PROCEDURE Bioelectric Impedance Analysis
  • PROCEDURE Cardiopulmonary Exercise Testing
  • PROCEDURE Physical Performance Testing

Study Locations (1)

California

  • City of Hope Medical Center - Duarte

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2020-11-18
Est. Completion 2026-06-30

Sponsor

City of Hope Medical Center

582 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04537871

The ClinicalTrials.gov registry entry for NCT04537871 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 115-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (204% higher). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Acute Myeloid Leukemia appearing as the primary indexed condition, and to 5 interventions - of which Biospecimen Collection is the first listed.

NCT04537871 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04537871 about?

NCT04537871 is a clinical study titled "Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study". This study evaluates how well the heart, lungs, and muscles are working individually, and how these systems are working together in transplant survivors. Information collected in this study may help doctors to understand why hematopoietic stem cell transplant survivors are at higher risk for develop...

What is the current status of trial NCT04537871?

This trial is currently active not recruiting. The enrollment target is 350 participants. The study started on 2020-11-18. Estimated completion is 2026-06-30.

What conditions does trial NCT04537871 study?

This clinical trial studies the following conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, Hematopoietic and Lymphoid Cell Neoplasm, Non-Hodgkin Lymphoma.

What interventions are being tested in trial NCT04537871?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Echocardiography (PROCEDURE), Bioelectric Impedance Analysis (PROCEDURE), Cardiopulmonary Exercise Testing (PROCEDURE), Physical Performance Testing (PROCEDURE).

Who is sponsoring clinical trial NCT04537871?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04537871 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acute Myeloid Leukemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acute Myeloid Leukemia

All registered trials for this condition

Myelodysplastic Syndrome

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.